-
-
-
-
-
-
-
![Comparison of novel PSMA-targeting [177Lu]Lu-P17-087 with its albumin binding derivative [177Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study](https://aidevmd.com/wp-content/uploads/2025/05/itinai.com_Light_and_Shadow_chase_in_a_bright_clinical_trial__46d6fec8-e34f-4900-920c-bc826aa5cb79_2.png)
Comparison of novel PSMA-targeting [177Lu]Lu-P17-087 with its albumin binding derivative [177Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study
“`html Study on PSMA-Targeting Radionuclide Therapy for Prostate Cancer Purpose:…
-
-
-
![Corrigendum to “Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial” [Eur J Cancer 198 (2024) 113475]](https://aidevmd.com/wp-content/uploads/2025/05/itinai.com_an_advertising_light_picture_for_medical_analysis__5c395afe-218e-4906-a405-4791096c0e54_3.png)
-
-
-
-
-
-
-
-
-
-
